ANDA 90622, held by Ethypharm. Buprenorphine Hydrochloride.
As of Nov 16, 2026, ANDA 90622 (Buprenorphine Hydrochloride), held by Ethypharm, was first approved by FDA on Sep 24, 2010, with 24 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 24, 2010 | Original application | Approved |
| Buprenorphine HydrochlorideEQ 2MG BASE · tablet;sublingual | Buprenorphine Hydrochloride | Rx |
| Buprenorphine HydrochlorideEQ 8MG BASE · tablet;sublingual | Buprenorphine Hydrochloride | Rx |
| Aug 14, 2026 | Supplement 47REMS | Approved | None posted |
| Dec 22, 2025 | Supplement 45Labeling · Standard review | Approved | None posted |
| Feb 21, 2025 | Supplement 44REMS | Approved | None posted |
| Mar 20, 2024 | Supplement 40REMS | Approved | None posted |
| Dec 15, 2023 | Supplement 42Labeling · Standard review | Approved | None posted |
| Jun 26, 2023 | Supplement 41Labeling · Standard review | Approved | None posted |
| Dec 16, 2022 | Supplement 37REMS | Approved | None posted |
| Jun 17, 2022 | Supplement 36Labeling · Standard review | Approved | None posted |
| Jun 17, 2022 | Supplement 34Labeling · Standard review | Approved | None posted |
| Jun 16, 2022 | Supplement 33Labeling · Standard review | Approved | None posted |
| May 3, 2022 | Supplement 35REMS | Approved | None posted |
| Mar 4, 2021 | Supplement 32Labeling · Standard review | Approved | None posted |
| Oct 9, 2019 | Supplement 30Labeling · Standard review | Approved | None posted |
| Oct 31, 2018 | Supplement 26REMS | Approved | None posted |
| Feb 1, 2018 | Supplement 25Labeling · Standard review | Approved | None posted |
| May 23, 2017 | Supplement 21REMS | Approved | None posted |
| Dec 16, 2016 | Supplement 19Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 18Labeling · Standard review | Approved | None posted |
| Jul 7, 2016 | Supplement 17REMS | Approved | None posted |
| Feb 12, 2015 | Supplement 12REMS | Approved | None posted |
| Feb 4, 2015 | Supplement 13Labeling · Standard review | Approved | None posted |
| Feb 4, 2015 | Supplement 6Labeling · Standard review | Approved | None posted |
| Sep 4, 2013 | Supplement 7REMS | Approved | None posted |
| Feb 22, 2013 | Supplement 5Labeling · Standard review | Approved | None posted |
| Sep 24, 2010 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters